The OncoRat®: Hosting valuable tumor xenograft models that are difficult or impossible to study using in vitro or mouse models
One of the most widely used methods of modeling human [...]
Patient derived xenograft studies from wider varieties of patient sub-populations promise improved clinical trial selection and design
Around 85% of preclinical drugs entering clinical trials in oncology [...]
OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars
While advances in in-vitro platforms have allowed researchers to better [...]
Hera Biolabs to present at the 2018 AACR Annual Meeting.
Hera Biolabs will be presenting xenograft, PDX, and humanization of [...]
Understanding Transporter-Mediated Drug-Drug Interactions Using Humanized Liver Mice
Pharmaceutical researchers and regulators are increasingly aware of the influence [...]
Using Patient Derived Xenografts to Improve Therapeutic Cancer Treatments
An increased understanding of human tumors has created a solid [...]
Humanized immune-system SRG Rats™ & mice for immuno-oncology
The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]
Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes
A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]
Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes
A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]
Using Cell Sheet Technique to Study the Development of HCC in Rat Models
As the single most prevalent primary liver cancer and the [...]